Skip to main content
Premium Trial:

Request an Annual Quote

BIO 2004 to Feature Announcements on Kangaroo Genome, DOL Biotech Investment

NEW YORK, May 28 (GenomeWeb News) - This year's BIO 2004 conference, held from June 6 to 9 in San Francisco, will be the site of at least a couple genomics- and proteomics-related announcements, the Biotechnology Industry Organization said yesterday.

 

Featured among these will be an update from the National Human Genome Research Institute on the Kangaroo Genome Project, and the announcement of $15 million in biotech investments by the US Department of Labor and the firm New Economy Strategies.

 

The DOL, which will provide its part of the money through its Employment and Training Administration as part of President Bush's High Growth Job Training Initiative, was not able to provide information on how much, if any, of the $15 million will go to genomics and proteomics research.

 

 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.